| Methods |
RCT comparing bezafibrate versus placebo in patients with coronary artery disease. |
| Data |
3122 patients were randomised (1542/1558, respectively in each treatment group), 32 patients were excluded from analysis because they never started the study medication. |
| Comparisons |
Onsite assessment (local investigator blinded) versus assessment by an AC blinded to allocated treatment. |
| Outcomes |
The outcome selected was fatal or non fatal myocardial infarction or sudden death. The study's primary outcome was time to one these events. |
| Notes |
Data related to the number of events in each treatment group resulting from onsite‐assessment were obtained directly from the study authors. |
| Risk of bias |
| Item |
Authors' judgement |
Description |
| Method for selecting cases to adjudicate? |
No |
All suspect events adjudicated were identified by onsite assessor who was blinded to allocated treatment. |
